Preview

Nephrology and Dialysis

Advanced search

Combination of glomerulonephritis and antiphospholipid syndrome nephropathy in systemic lupus erythematosus (review and case report)

Abstract

Combination of lupus nephritis and antiphospholipid syndrome nephropathy may occure in patients with SLE, complicated with antiphospholipid syndrome, in 32-68% of cases. Clinical manifestations of antiphospholipid syndrome nephropathy and proliferative lupus nephritis, such as arterial hypertension and progressive renal failure may be similar, and often only renal biopsy can help to make a proper diagnosis and choose adequate treatment strategy. Serial renal biopsies may help not only in assessing degree of activity and the progression of chronicity of lupus nephritis, but may also show possible class transformation. Transitions in lupus nephritis are not unusual and almost any class has been documented to go to any other class. Successful treatment of diffuse proliferative lupus nephritis may result in the transformation to membranous LN. The pediatric patient with biopsy proven LN class IV developed flare with dialysis-dependent renal failure due to superimposition of thrombotic microangiopathy. The case illustrates the difficulties of diagnostics, only the second biopsy, performed 7 months later and after 4 month of aggressive immunosupression with steroids and cyclophosphamide, indicated the presence of thrombotic microangiopathy with glomerular ischemia and transformation of the LN to class V. Interestingly, there were no other clinical symptoms of APS, anticardiolipin antybodies were in normal range, and only presence of lupus anticoagulant, found after second biopsy, supported diagnosis of APS. Addition of long-term anticoagulant therapy lead to partial restoration of renal function, so that patient became dialysis-free after 22 months of treatment. Supportive treatment with low-dose steroids, mycophenolates and warfarin allows to maintain remission over 18 months.

About the Authors

N. L. Kozlovskaja
Кафедра нефрологии и гемодиализа ММА имени И.М. Сеченова
Russian Federation


E. V. Zakharova
Московская городская клиническая больница имени С.П. Боткина
Russian Federation


D. V. Zverev
Детская городская клиническая больница Святого Владимира
Russian Federation


A. V. Sukhanov
Научно-исследовательский институт трансплантологии и искусственных органов, г. Москва
Russian Federation


A. H. Cohen
Отдел патологии и лабораторной медицины, медицинский центр Cedars-Sinai, Лос-Анджелес, США
Russian Federation


O. N. Avdeeva
Детская городская клиническая больница Святого Владимира
Russian Federation


S. N. Epifanova
Детская городская клиническая больница Святого Владимира
Russian Federation


References

1. Козловская Н.Л., Шилов Е.М., Метелева Н.А. и соавт. Клинические и морфологические особенности волчаночного нефрита при системной красной волчанке с антифосфолипидным синдромом. Терапевт. архив 2006; 5: 21-31.

2. Козловская Н.Л. Нефропатия, ассоциированная с антифосфолипидным синдромом: клинико-морфологическая характеристика, диагностика, лечение. Автореф. дисс. доктора мед. наук. М.: 2006.

3. Amigo M.-C., Garcia-Torres R., Robles M. et al. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992; 19: 1181-1185.

4. Appel G.B., Pirani C.L., D´Agati V. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 1994; 4: 1499-1515.

5. Banfi G., Bertani T., Boery V. et al. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis 1991; 18: 240-248.

6. Bhandari S., Harnden P., Brownjohn A.M., Turney J.H. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. Quart J Med 1998; 91: 401-409.

7. Bridoux F., Vrtovsnik F., Noel Ch. et al. Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long - term renal survival. Nephrol Dial Transplant 1998; 13: 298-304.

8. Daugas E., Nochy D., Thi Huong D.L. et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus J Am Soc Nephrol 2002; 13: 42-52.

9. Descombes E., Droz D., Drouet L. et al. Renal vascular lesions in lupus nephritis. Medicine 1997; 76: 355-368.

10. Domrongkitchaiporn S., Cameron E.C., Jetha N. et al. Renal microangiopathy in the primary antiphospholipid syndrome: a case report with literature review. Nephron 1994; 68: 128-132.

11. Farrugia E., Torres V.E., Gastineau D. et al. Lupus anticoagulant in systemic lupus erytematosus: a clinical and renal pathological study. Am J Kidney Dis 1992; 20: 463-471.

12. Fofi C., Cuadrado M.J., Godfrey T. et al. Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis. Clin Exp Rheumatol 2001: 19; 75-77.

13. Frampton G., Hicks J., Cameron J.S. Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int 1991; 39: 1225-1231.

14. Griffiths M.H., Papadaki L., Neild G.H. The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial indjury. Quart J Med 2000; 93: 457-467.

15. Kant K.S., Pollak V.E., Weiss M.A. et al. Glomerular thrombosis in systemic lupus erythematosus : prevalence and significance. Medicine 1981; 60 (7): 71-85.

16. Kincaid-Smith P., Fairley K.F., Kloss M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med 1988; 69: 795-815.

17. Kleinknecht D., Bobrie G., Meyer O. et al. Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant. Nephrol Dial Transplant 1989; 4: 854-858.

18. Klemperer P., Pollak A.D., Baehr G. Pathology of disseminated lupus erythematosus. Arch Pathol 1941; 32: 569-631.

19. Leaker B., McGregor A., Griffits M. et al. Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt lupus nephritis. Brit J Rheumatol 1991; 30: 422-425.

20. Moroni G., Ventura D., Riva P. et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 2004; 43 (1): 28-36.

21. Moss K.E., Isenberg D.A. Comparison of renal disease and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. J Rheumatol 2001; 40: 863-867.

22. Nochy D., Daugas E., Droz D. et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 1999; 10: 507-518.

23. Piette J.C., Kleinknecht D., Bach J.-F. Renal manifestation in the antiphospholipid syndrome. In: Asherson R., Cervera R., Piette J.C., Schoenfeld Y. (eds.) The antiphospholipid syndrome. Boca Raton: CRC Press; 1996: 169-181.

24. Ponticelli C., Moroni G. Lupus nephritis. J Am Soc Nephrol 1999; 10: 413-424.

25. Rollino C., Mazzucco G., Boero R. et al. Is it possible to diagnose primary antiphospholipid syndrome (PAPS) on the basis of renal thrombotic microangiopathy (PAPS nephropathy) in the absence of other thrombotic process? Ren Fail 2003; 25 (6): 1043-1049.

26. Schwartz M.M. Lupus vasculatis. Contrib Nephrol 1992; 99: 35-45.

27. Sipek-Dolnicar A., Hojnik M., Rozman B. et al. Small vessel thrombosis without thrombotic events in systemic lupus erythrmatosus patients with antiphospholipid syndrome. Wien Klin Wochenschr 2000; 112 (15-16): 707-710.

28. Sipek-Dolnicar A., Hojnic M., Bozic B. et al. Clinical presentation and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies. Clin Exp Rheumatol 2002; 20 (3): 335-342.

29. Tectonidou M.G., Sotsiou F., Nakopoulou L. et al. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations and long-term outcome. Arthritis Rheum 2004; 50 (8): 2569-2579.


Review

For citations:


Kozlovskaja N.L., Zakharova E.V., Zverev D.V., Sukhanov A.V., Cohen A.H., Avdeeva O.N., Epifanova S.N. Combination of glomerulonephritis and antiphospholipid syndrome nephropathy in systemic lupus erythematosus (review and case report). Nephrology and Dialysis. 2007;9(4):439-446. (In Russ.)

Views: 3


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1680-4422 (Print)
ISSN 2618-9801 (Online)